![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 1Cambrex, Karlskoga AB
Reset all filters
01 1Samoh Pharmaceutical Co., Ltd.
Reset all filters
01 1Remimazolam besylate
Reset all filters
01 1U.S.A
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2021-01-07
Registration Number : Su0106-1-ND
Manufacturer Name : Cambrex, Karlskoga AB
Manufacturer Address : Bjorkborn Industriomrade Karlskoga, 691 85 Sweden
A Remimazolam Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Remimazolam Besylate, including repackagers and relabelers. The FDA regulates Remimazolam Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Remimazolam Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Remimazolam Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Remimazolam Besylate supplier is an individual or a company that provides Remimazolam Besylate active pharmaceutical ingredient (API) or Remimazolam Besylate finished formulations upon request. The Remimazolam Besylate suppliers may include Remimazolam Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Remimazolam Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Remimazolam Besylate Drug Master File in Korea (Remimazolam Besylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Remimazolam Besylate. The MFDS reviews the Remimazolam Besylate KDMF as part of the drug registration process and uses the information provided in the Remimazolam Besylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Remimazolam Besylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Remimazolam Besylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Remimazolam Besylate suppliers with KDMF on PharmaCompass.
We have 1 companies offering Remimazolam Besylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?